UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Forza Wealth Management LLC

Forza Wealth Management LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 30.8% during the 1st quarter, HoldingsChannel reports. The firm owned 583 shares of the healthcare conglomerate’s stock after selling 260 shares during the period. Forza Wealth Management LLC’s holdings in UnitedHealth Group were worth $288,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Robbins Farley acquired a new stake in shares of UnitedHealth Group in the 3rd quarter worth $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group during the fourth quarter worth about $26,000. CGC Financial Services LLC boosted its holdings in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $31,000. Finally, NewSquare Capital LLC lifted its holdings in UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 1.3 %

Shares of UnitedHealth Group stock traded down $6.35 on Monday, reaching $489.00. 2,192,486 shares of the company were exchanged, compared to its average volume of 4,479,956. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The stock’s 50 day moving average price is $485.19 and its 200-day moving average price is $513.81. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a market cap of $449.92 billion, a P/E ratio of 29.89, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the previous year, the company earned $6.26 EPS. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Barclays lifted their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

Check Out Our Latest Report on UNH

Insiders Place Their Bets

In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.